Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Certificate of Incorporation of Virpax Pharmaceuticals, Inc., As Currently In Effect.
- 3.3 Bylaws of Virpax Pharmaceuticals, Inc., As Currently In Effect.
- 4.1 Specimen Certificate Representing Shares of Common Stock of Virpax Pharmaceuticals, Inc
- 4.3 Form of Consultant Warrant
- 10.2 Virpax Pharmaceuticals, Inc. 2017 Equity Incentive Plan.
- 10.3 Form of Nonqualified Stock Option Award Under 2017 Equity Incentive Plan.
- 10.4 Form of Incentive Stock Option Award Under 2017 Equity Incentive Plan.
- 10.5 Employment Agreement by and Between Virpax Pharmaceuticals, Inc. and Anthony Mack, Dated As of September 18, 2018
- 10.6 Consulting Agreement by and Between Virpax Pharmaceuticals, Inc. and Gerald Bruce, Dated As of March 11, 2020
- 10.20 Promissory Note, Dated October 1, 2018, Between Anthony Mack and Virpax Pharmaceuticals, Inc.
- 10.21 Amendment No. 1 to the Promissory Note Dated October 1, 2018, Dated April 6, 2020, Between Anthony Mack and Virpax Pharmaceuticals, Inc.
- 10.22 Promissory Note, Dated January 15, 2019, Between Anthony Mack and Virpax Pharmaceuticals, Inc.
- 10.23 Amendment No. 1 to the Promissory Note Dated January 15, 2019, Dated April 6, 2020, Between Anthony Mack and Virpax Pharmaceuticals, Inc.
- 10.24 Service Provider Convertible Note Purchase Agreement, Dated August 29, 2019, Between Virpax Pharmaceuticals, Inc. and RRD International, LLC
- 10.25 First Amendment to the Services Convertible Promissory Note, Dated March 25, 2020, Between Virpax Pharmaceuticals, Inc. and RRD International, LLC
- 10.26 Second Amendment to the Services Convertible Promissory Note, Dated As of September 30, 2020, Between Virpax Pharmaceuticals, Inc. and RRD International, LLC
- 10.27 Paycheck Protection Program Term Note, Dated May 4, 2020, Between Virpax Pharmaceuticals, Inc. and PNC Bank, National Association
- 10.28 Cooperative Research and Development Agreement, Dated August 25, 2020, Between the U.S. Department of Health and Human Services
- 10.29 Independent Contractor Agreement, Dated May 1, 2020, Between Virpax Pharmaceuticals, Inc. and Chipman & Chipman, LLC
- 23.1 Consent of Eisneramper LLP, Independent Registered Public Accounting Firm for the Financial Statements of Virpax Pharmaceuticals, Inc
Associated filings
- 18 Feb 21 POS EX Additional exhibits for listing
- 18 Feb 21 424B4 Prospectus supplement with pricing info
- 17 Feb 21 EFFECT Notice of effectiveness
- 2 Feb 21 S-1/A IPO registration (amended)
- 8 Jan 21 FWP Free writing prospectus
- 8 Jan 21 S-1/A IPO registration (amended)
- 16 Dec 20 S-1/A IPO registration (amended)
- 20 Nov 20 S-1/A IPO registration (amended)
-
9 Oct 20 S-1 IPO registration
VRPX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement of Virpax Pharmaceuticals, Inc. on Form S-1 to be filed on or about October 9, 2020 of our report dated August 10, 2020, on our audits of the consolidated financial statements as of December 31, 2019 and 2018 and for each of the years then ended. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a going concern. We also consent to the reference to our firm under the caption “Experts” in this Registration Statement.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Philadelphia, Pennsylvania
October 9, 2020